Table of Content

1 VLP Vaccines Market Overview
1.1 VLP Vaccines Product Overview
1.2 VLP Vaccines Market Segment by Type
1.2.1 HPV Vaccine
1.2.2 Covid-19 Vaccine
1.2.3 Hepatitis B Vaccine
1.2.4 Others
1.3 Global VLP Vaccines Market Size by Type
1.3.1 Global VLP Vaccines Market Size Overview by Type (2024-2034)
1.3.2 Global VLP Vaccines Historic Market Size Review by Type (2024-2024)
1.3.3 Global VLP Vaccines Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America VLP Vaccines Sales Breakdown by Type (2024-2024)
1.4.2 Europe VLP Vaccines Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific VLP Vaccines Sales Breakdown by Type (2024-2024)
1.4.4 Latin America VLP Vaccines Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa VLP Vaccines Sales Breakdown by Type (2024-2024)
2 Global VLP Vaccines Market Competition by Company
2.1 Global Top Players by VLP Vaccines Sales (2024-2024)
2.2 Global Top Players by VLP Vaccines Revenue (2024-2024)
2.3 Global Top Players by VLP Vaccines Price (2024-2024)
2.4 Global Top Manufacturers VLP Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 VLP Vaccines Market Competitive Situation and Trends
2.5.1 VLP Vaccines Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by VLP Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in VLP Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into VLP Vaccines Market
2.8 Key Manufacturers VLP Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 VLP Vaccines Status and Outlook by Region
3.1 Global VLP Vaccines Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global VLP Vaccines Historic Market Size by Region
3.2.1 Global VLP Vaccines Sales in Volume by Region (2024-2024)
3.2.2 Global VLP Vaccines Sales in Value by Region (2024-2024)
3.2.3 Global VLP Vaccines Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global VLP Vaccines Forecasted Market Size by Region
3.3.1 Global VLP Vaccines Sales in Volume by Region (2024-2034)
3.3.2 Global VLP Vaccines Sales in Value by Region (2024-2034)
3.3.3 Global VLP Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global VLP Vaccines by Application
4.1 VLP Vaccines Market Segment by Application
4.1.1 Government
4.1.2 Medical Institution
4.1.3 Others
4.2 Global VLP Vaccines Market Size by Application
4.2.1 Global VLP Vaccines Market Size Overview by Application (2024-2034)
4.2.2 Global VLP Vaccines Historic Market Size Review by Application (2024-2024)
4.2.3 Global VLP Vaccines Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America VLP Vaccines Sales Breakdown by Application (2024-2024)
4.3.2 Europe VLP Vaccines Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific VLP Vaccines Sales Breakdown by Application (2024-2024)
4.3.4 Latin America VLP Vaccines Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa VLP Vaccines Sales Breakdown by Application (2024-2024)
5 North America VLP Vaccines by Country
5.1 North America VLP Vaccines Historic Market Size by Country
5.1.1 North America VLP Vaccines Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America VLP Vaccines Sales in Volume by Country (2024-2024)
5.1.3 North America VLP Vaccines Sales in Value by Country (2024-2024)
5.2 North America VLP Vaccines Forecasted Market Size by Country
5.2.1 North America VLP Vaccines Sales in Volume by Country (2024-2034)
5.2.2 North America VLP Vaccines Sales in Value by Country (2024-2034)
6 Europe VLP Vaccines by Country
6.1 Europe VLP Vaccines Historic Market Size by Country
6.1.1 Europe VLP Vaccines Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe VLP Vaccines Sales in Volume by Country (2024-2024)
6.1.3 Europe VLP Vaccines Sales in Value by Country (2024-2024)
6.2 Europe VLP Vaccines Forecasted Market Size by Country
6.2.1 Europe VLP Vaccines Sales in Volume by Country (2024-2034)
6.2.2 Europe VLP Vaccines Sales in Value by Country (2024-2034)
7 Asia-Pacific VLP Vaccines by Region
7.1 Asia-Pacific VLP Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific VLP Vaccines Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific VLP Vaccines Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific VLP Vaccines Sales in Value by Region (2024-2024)
7.2 Asia-Pacific VLP Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific VLP Vaccines Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific VLP Vaccines Sales in Value by Region (2024-2034)
8 Latin America VLP Vaccines by Country
8.1 Latin America VLP Vaccines Historic Market Size by Country
8.1.1 Latin America VLP Vaccines Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America VLP Vaccines Sales in Volume by Country (2024-2024)
8.1.3 Latin America VLP Vaccines Sales in Value by Country (2024-2024)
8.2 Latin America VLP Vaccines Forecasted Market Size by Country
8.2.1 Latin America VLP Vaccines Sales in Volume by Country (2024-2034)
8.2.2 Latin America VLP Vaccines Sales in Value by Country (2024-2034)
9 Middle East and Africa VLP Vaccines by Country
9.1 Middle East and Africa VLP Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa VLP Vaccines Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa VLP Vaccines Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa VLP Vaccines Sales in Value by Country (2024-2024)
9.2 Middle East and Africa VLP Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa VLP Vaccines Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa VLP Vaccines Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Medicago
10.1.1 Medicago Company Information
10.1.2 Medicago Introduction and Business Overview
10.1.3 Medicago VLP Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Medicago VLP Vaccines Products Offered
10.1.5 Medicago Recent Development
10.2 Novavax
10.2.1 Novavax Company Information
10.2.2 Novavax Introduction and Business Overview
10.2.3 Novavax VLP Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Novavax VLP Vaccines Products Offered
10.2.5 Novavax Recent Development
10.3 Saiba Animal Health
10.3.1 Saiba Animal Health Company Information
10.3.2 Saiba Animal Health Introduction and Business Overview
10.3.3 Saiba Animal Health VLP Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Saiba Animal Health VLP Vaccines Products Offered
10.3.5 Saiba Animal Health Recent Development
10.4 VBI
10.4.1 VBI Company Information
10.4.2 VBI Introduction and Business Overview
10.4.3 VBI VLP Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.4.4 VBI VLP Vaccines Products Offered
10.4.5 VBI Recent Development
10.5 ARTES Biotechnology
10.5.1 ARTES Biotechnology Company Information
10.5.2 ARTES Biotechnology Introduction and Business Overview
10.5.3 ARTES Biotechnology VLP Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.5.4 ARTES Biotechnology VLP Vaccines Products Offered
10.5.5 ARTES Biotechnology Recent Development
10.6 VLP Therapeutics
10.6.1 VLP Therapeutics Company Information
10.6.2 VLP Therapeutics Introduction and Business Overview
10.6.3 VLP Therapeutics VLP Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.6.4 VLP Therapeutics VLP Vaccines Products Offered
10.6.5 VLP Therapeutics Recent Development
10.7 POSVAX
10.7.1 POSVAX Company Information
10.7.2 POSVAX Introduction and Business Overview
10.7.3 POSVAX VLP Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.7.4 POSVAX VLP Vaccines Products Offered
10.7.5 POSVAX Recent Development
10.8 Spybiotech
10.8.1 Spybiotech Company Information
10.8.2 Spybiotech Introduction and Business Overview
10.8.3 Spybiotech VLP Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Spybiotech VLP Vaccines Products Offered
10.8.5 Spybiotech Recent Development
10.9 Optipharm Co. Ltd
10.9.1 Optipharm Co. Ltd Company Information
10.9.2 Optipharm Co. Ltd Introduction and Business Overview
10.9.3 Optipharm Co. Ltd VLP Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Optipharm Co. Ltd VLP Vaccines Products Offered
10.9.5 Optipharm Co. Ltd Recent Development
10.10 H&Z Life Science
10.10.1 H&Z Life Science Company Information
10.10.2 H&Z Life Science Introduction and Business Overview
10.10.3 H&Z Life Science VLP Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.10.4 H&Z Life Science VLP Vaccines Products Offered
10.10.5 H&Z Life Science Recent Development
10.11 Gproan
10.11.1 Gproan Company Information
10.11.2 Gproan Introduction and Business Overview
10.11.3 Gproan VLP Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Gproan VLP Vaccines Products Offered
10.11.5 Gproan Recent Development
10.12 Merck
10.12.1 Merck Company Information
10.12.2 Merck Introduction and Business Overview
10.12.3 Merck VLP Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Merck VLP Vaccines Products Offered
10.12.5 Merck Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 VLP Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 VLP Vaccines Industrial Chain Analysis
11.4 VLP Vaccines Market Dynamics
11.4.1 VLP Vaccines Industry Trends
11.4.2 VLP Vaccines Market Drivers
11.4.3 VLP Vaccines Market Challenges
11.4.4 VLP Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 VLP Vaccines Distributors
12.3 VLP Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of HPV Vaccine
Table 2. Major Company of Covid-19 Vaccine
Table 3. Major Company of Hepatitis B Vaccine
Table 4. Major Company of Others
Table 5. Global VLP Vaccines Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 6. Global VLP Vaccines Sales by Type (2024-2024) & (K Doses)
Table 7. Global VLP Vaccines Sales Market Share in Volume by Type (2024-2024)
Table 8. Global VLP Vaccines Sales by Type (2024-2024) & (US& Million)
Table 9. Global VLP Vaccines Market Share in Value by Type (2024-2024)
Table 10. Global VLP Vaccines Price by Type (2024-2024) & (US$/Dose)
Table 11. Global VLP Vaccines Sales by Type (2024-2034) & (K Doses)
Table 12. Global VLP Vaccines Sales Market Share in Volume by Type (2024-2034)
Table 13. Global VLP Vaccines Sales by Type (2024-2034) & (US$ Million)
Table 14. Global VLP Vaccines Sales Market Share in Value by Type (2024-2034)
Table 15. Global VLP Vaccines Price by Type (2024-2034) & (US$/Dose)
Table 16. North America VLP Vaccines Sales by Type (2024-2024) & (K Doses)
Table 17. North America VLP Vaccines Sales by Type (2024-2024) & (US$ Million)
Table 18. Europe VLP Vaccines Sales (K Doses) by Type (2024-2024)
Table 19. Europe VLP Vaccines Sales by Type (2024-2024) & (US$ Million)
Table 20. Asia-Pacific VLP Vaccines Sales (K Doses) by Type (2024-2024)
Table 21. Asia-Pacific VLP Vaccines Sales by Type (2024-2024) & (US$ Million)
Table 22. Latin America VLP Vaccines Sales (K Doses) by Type (2024-2024)
Table 23. Latin America VLP Vaccines Sales by Type (2024-2024) & (US$ Million)
Table 24. Middle East and Africa VLP Vaccines Sales (K Doses) by Type (2024-2024)
Table 25. Middle East and Africa VLP Vaccines Sales by Type (2024-2024) & (US$ Million)
Table 26. Global VLP Vaccines Sales by Company (2024-2024) & (K Doses)
Table 27. Global VLP Vaccines Sales Share by Company (2024-2024)
Table 28. Global VLP Vaccines Revenue by Company (2024-2024) & (US$ Million)
Table 29. Global VLP Vaccines Revenue Share by Company (2024-2024)
Table 30. Global Market VLP Vaccines Price by Company (2024-2024) & (US$/Dose)
Table 31. Global VLP Vaccines Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global VLP Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in VLP Vaccines as of 2022)
Table 34. Date of Key Manufacturers Enter into VLP Vaccines Market
Table 35. Key Manufacturers VLP Vaccines Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global VLP Vaccines Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 38. Global VLP Vaccines Sales by Region (2024-2024) & (K Doses)
Table 39. Global VLP Vaccines Sales Market Share in Volume by Region (2024-2024)
Table 40. Global VLP Vaccines Sales by Region (2024-2024) & (US$ Million)
Table 41. Global VLP Vaccines Sales Market Share in Value by Region (2024-2024)
Table 42. Global VLP Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 43. Global VLP Vaccines Sales by Region (2024-2034) & (K Doses)
Table 44. Global VLP Vaccines Sales Market Share in Volume by Region (2024-2034)
Table 45. Global VLP Vaccines Sales by Region (2024-2034) & (US$ Million)
Table 46. Global VLP Vaccines Sales Market Share in Value by Region (2024-2034)
Table 47. Global VLP Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2034)
Table 48. Global VLP Vaccines Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 49. Global VLP Vaccines Sales by Application (2024-2024) & (K Doses)
Table 50. Global VLP Vaccines Sales Market Share in Volume by Application (2024-2024)
Table 51. Global VLP Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 52. Global VLP Vaccines Sales Market Share in Value by Application (2024-2024)
Table 53. Global VLP Vaccines Price by Application (2024-2024) & (US$/Dose)
Table 54. Global VLP Vaccines Sales by Application (2024-2034) & (K Doses)
Table 55. Global VLP Vaccines Sales Market Share in Volume by Application (2024-2034)
Table 56. Global VLP Vaccines Sales by Application (2024-2034) & (US$ Million)
Table 57. Global VLP Vaccines Sales Market Share in Value by Application (2024-2034)
Table 58. Global VLP Vaccines Price by Application (2024-2034) & (US$/Dose)
Table 59. North America VLP Vaccines Sales by Application (2024-2024) (K Doses)
Table 60. North America VLP Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 61. Europe VLP Vaccines Sales by Application (2024-2024) (K Doses)
Table 62. Europe VLP Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 63. Asia-Pacific VLP Vaccines Sales by Application (2024-2024) (K Doses)
Table 64. Asia-Pacific VLP Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 65. Latin America VLP Vaccines Sales by Application (2024-2024) (K Doses)
Table 66. Latin America VLP Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 67. Middle East and Africa VLP Vaccines Sales by Application (2024-2024) (K Doses)
Table 68. Middle East and Africa VLP Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 69. North America VLP Vaccines Sales by Country (2024-2024) & (K Doses)
Table 70. North America VLP Vaccines Sales Market Share in Volume by Country (2024-2024)
Table 71. North America VLP Vaccines Sales by Country (2024-2024) & (US$ Million)
Table 72. North America VLP Vaccines Sales Market Share in Value by Country (2024-2024)
Table 73. North America VLP Vaccines Sales by Country (2024-2034) & (K Doses)
Table 74. North America VLP Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 75. North America VLP Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 76. North America VLP Vaccines Sales Market Share in Value by Country (2024-2034)
Table 77. Europe VLP Vaccines Sales by Country (2024-2024) & (K Doses)
Table 78. Europe VLP Vaccines Sales Market Share in Volume by Country (2024-2024)
Table 79. Europe VLP Vaccines Sales by Country (2024-2024) & (US$ Million)
Table 80. Europe VLP Vaccines Sales Market Share in Value by Country (2024-2024)
Table 81. Europe VLP Vaccines Sales by Country (2024-2034) & (K Doses)
Table 82. Europe VLP Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe VLP Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe VLP Vaccines Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific VLP Vaccines Sales by Region (2024-2024) & (K Doses)
Table 86. Asia-Pacific VLP Vaccines Sales Market Share in Volume by Region (2024-2024)
Table 87. Asia-Pacific VLP Vaccines Sales by Region (2024-2024) & (US$ Million)
Table 88. Asia-Pacific VLP Vaccines Sales Market Share in Value by Region (2024-2024)
Table 89. Asia-Pacific VLP Vaccines Sales by Region (2024-2034) & (K Doses)
Table 90. Asia-Pacific VLP Vaccines Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific VLP Vaccines Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific VLP Vaccines Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America VLP Vaccines Sales by Country (2024-2024) & (K Doses)
Table 94. Latin America VLP Vaccines Sales Market Share in Volume by Country (2024-2024)
Table 95. Latin America VLP Vaccines Sales by Country (2024-2024) & (US$ Million)
Table 96. Latin America VLP Vaccines Sales Market Share in Value by Country (2024-2024)
Table 97. Latin America VLP Vaccines Sales by Country (2024-2034) & (K Doses)
Table 98. Latin America VLP Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America VLP Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America VLP Vaccines Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa VLP Vaccines Sales by Country (2024-2024) & (K Doses)
Table 102. Middle East and Africa VLP Vaccines Sales Market Share in Volume by Country (2024-2024)
Table 103. Middle East and Africa VLP Vaccines Sales by Country (2024-2024) & (US$ Million)
Table 104. Middle East and Africa VLP Vaccines Sales Market Share in Value by Country (2024-2024)
Table 105. Middle East and Africa VLP Vaccines Sales by Country (2024-2034) & (K Doses)
Table 106. Middle East and Africa VLP Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa VLP Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa VLP Vaccines Sales Market Share in Value by Country (2024-2034)
Table 109. Medicago Company Information
Table 110. Medicago Introduction and Business Overview
Table 111. Medicago VLP Vaccines Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 112. Medicago VLP Vaccines Product
Table 113. Medicago Recent Development
Table 114. Novavax Company Information
Table 115. Novavax Introduction and Business Overview
Table 116. Novavax VLP Vaccines Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 117. Novavax VLP Vaccines Product
Table 118. Novavax Recent Development
Table 119. Saiba Animal Health Company Information
Table 120. Saiba Animal Health Introduction and Business Overview
Table 121. Saiba Animal Health VLP Vaccines Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 122. Saiba Animal Health VLP Vaccines Product
Table 123. Saiba Animal Health Recent Development
Table 124. VBI Company Information
Table 125. VBI Introduction and Business Overview
Table 126. VBI VLP Vaccines Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 127. VBI VLP Vaccines Product
Table 128. VBI Recent Development
Table 129. ARTES Biotechnology Company Information
Table 130. ARTES Biotechnology Introduction and Business Overview
Table 131. ARTES Biotechnology VLP Vaccines Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 132. ARTES Biotechnology VLP Vaccines Product
Table 133. ARTES Biotechnology Recent Development
Table 134. VLP Therapeutics Company Information
Table 135. VLP Therapeutics Introduction and Business Overview
Table 136. VLP Therapeutics VLP Vaccines Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 137. VLP Therapeutics VLP Vaccines Product
Table 138. VLP Therapeutics Recent Development
Table 139. POSVAX Company Information
Table 140. POSVAX Introduction and Business Overview
Table 141. POSVAX VLP Vaccines Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 142. POSVAX VLP Vaccines Product
Table 143. POSVAX Recent Development
Table 144. Spybiotech Company Information
Table 145. Spybiotech Introduction and Business Overview
Table 146. Spybiotech VLP Vaccines Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 147. Spybiotech VLP Vaccines Product
Table 148. Spybiotech Recent Development
Table 149. Optipharm Co. Ltd Company Information
Table 150. Optipharm Co. Ltd Introduction and Business Overview
Table 151. Optipharm Co. Ltd VLP Vaccines Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 152. Optipharm Co. Ltd VLP Vaccines Product
Table 153. Optipharm Co. Ltd Recent Development
Table 154. H&Z Life Science Company Information
Table 155. H&Z Life Science Introduction and Business Overview
Table 156. H&Z Life Science VLP Vaccines Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 157. H&Z Life Science VLP Vaccines Product
Table 158. H&Z Life Science Recent Development
Table 159. Gproan Company Information
Table 160. Gproan Introduction and Business Overview
Table 161. Gproan VLP Vaccines Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 162. Gproan VLP Vaccines Product
Table 163. Gproan Recent Development
Table 164. Merck Company Information
Table 165. Merck Introduction and Business Overview
Table 166. Merck VLP Vaccines Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 167. Merck VLP Vaccines Product
Table 168. Merck Recent Development
Table 169. Key Raw Materials Lists
Table 170. Raw Materials Key Suppliers Lists
Table 171. VLP Vaccines Market Trends
Table 172. VLP Vaccines Market Drivers
Table 173. VLP Vaccines Market Challenges
Table 174. VLP Vaccines Market Restraints
Table 175. VLP Vaccines Distributors List
Table 176. VLP Vaccines Downstream Customers
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of Figures
Figure 1. VLP Vaccines Product Picture
Figure 2. Global VLP Vaccines Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global VLP Vaccines Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global VLP Vaccines Sales Status and Outlook (2024-2034) & (K Doses)
Figure 5. Product Picture of HPV Vaccine
Figure 6. Global HPV Vaccine Sales YoY Growth (2024-2034) & (K Doses)
Figure 7. Product Picture of Covid-19 Vaccine
Figure 8. Global Covid-19 Vaccine Sales YoY Growth (2024-2034) & (K Doses)
Figure 9. Product Picture of Hepatitis B Vaccine
Figure 10. Global Hepatitis B Vaccine Sales YoY Growth (2024-2034) & (K Doses)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2024-2034) & (K Doses)
Figure 13. Global VLP Vaccines Sales by Type (2024-2034) & (US$ Million)
Figure 14. Global VLP Vaccines Sales Market Share by Type in 2022 & 2034
Figure 15. North America VLP Vaccines Sales Market Share in Volume by Type in 2022
Figure 16. North America VLP Vaccines Sales Market Share in Value by Type in 2022
Figure 17. Europe VLP Vaccines Sales Market Share in Volume by Type in 2022
Figure 18. Europe VLP Vaccines Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific VLP Vaccines Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific VLP Vaccines Sales Market Share in Value by Type in 2022
Figure 21. Latin America VLP Vaccines Sales Market Share in Volume by Type in 2022
Figure 22. Latin America VLP Vaccines Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa VLP Vaccines Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa VLP Vaccines Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by VLP Vaccines Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by VLP Vaccines Revenue in 2022
Figure 27. VLP Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 28. Product Picture of Government
Figure 29. Global Government Sales YoY Growth (2024-2034) & (K Doses)
Figure 30. Product Picture of Medical Institution
Figure 31. Global Medical Institution Sales YoY Growth (2024-2034) & (K Doses)
Figure 32. Product Picture of Others
Figure 33. Global Others Sales YoY Growth (2024-2034) & (K Doses)
Figure 34. Global VLP Vaccines Sales by Application (2024-2034) & (US$ Million)
Figure 35. Global VLP Vaccines Sales Market Share by Application in 2022 & 2034
Figure 36. North America VLP Vaccines Sales Market Share in Volume by Application in 2022
Figure 37. North America VLP Vaccines Sales Market Share in Value by Application in 2022
Figure 38. Europe VLP Vaccines Sales Market Share in Volume by Application in 2022
Figure 39. Europe VLP Vaccines Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific VLP Vaccines Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific VLP Vaccines Sales Market Share in Value by Application in 2022
Figure 42. Latin America VLP Vaccines Sales Market Share in Volume by Application in 2022
Figure 43. Latin America VLP Vaccines Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa VLP Vaccines Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. VLP Vaccines Manufacturing Cost Structure
Figure 47. VLP Vaccines Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed